TY - JOUR
T1 - Why Consider Self-Sampling for Cervical Cancer Screening in Low- and Middle-Income Countries?
AU - Fokom Defo, Victoire
AU - Fokom Domgue, Joël
N1 - Publisher Copyright:
© 2020 American Medical Association. All Rights Reserved.
PY - 2020/2/1
Y1 - 2020/2/1
N2 - Molecular detection of high-risk human papillomavirus (HPV) in genital cells is being widely endorsed as a preferred tool for cervical cancer screening globally. In low- and middle-income countries (LMICs) where cervical cancer remains a leading killer, HPV testing is an appealing, accessible alternative to traditional cytology (ie, Pap smear) screening that enables women to self-collect specimens. This article examines self-sampling and its suitability as a strategy for cervical cancer prevention in LMICs that would promote equitable access to cervical cancer screening.
AB - Molecular detection of high-risk human papillomavirus (HPV) in genital cells is being widely endorsed as a preferred tool for cervical cancer screening globally. In low- and middle-income countries (LMICs) where cervical cancer remains a leading killer, HPV testing is an appealing, accessible alternative to traditional cytology (ie, Pap smear) screening that enables women to self-collect specimens. This article examines self-sampling and its suitability as a strategy for cervical cancer prevention in LMICs that would promote equitable access to cervical cancer screening.
UR - http://www.scopus.com/inward/record.url?scp=85079334702&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85079334702&partnerID=8YFLogxK
U2 - 10.1001/amajethics.2020.116
DO - 10.1001/amajethics.2020.116
M3 - Article
C2 - 32048582
AN - SCOPUS:85079334702
SN - 2376-6980
VL - 22
SP - E116-E125
JO - AMA journal of ethics
JF - AMA journal of ethics
IS - 2
ER -